| 國立成功大學 |
2023 |
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized
|
Chiu, Y.-F.;Liu, T.-W.;Shan, Y.-S.;Chen, J.-S.;Li, C.-P.;Ho, C.-L.;Hsieh, R.-K.;Hwang, T.-L.;Chen, L.-T.;Ch'ang, H.-J. |
| 國立成功大學 |
2023 |
Determinants of quality of life related to lower limb lymphedema in women with gynecological cancer surgery
|
Hsu, Y.-Y.;Liu, C.-Y.;Ho, C.-L.;Hsu, K.-F. |
| 臺大學術典藏 |
2022-06-27T07:02:08Z |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial
|
Yang J.C.H.; Shih J.-Y.; Su W.-C.; Hsia T.-C.; Tsai C.-M.; Ou S.H.I.; CHONG-JEN YU; Chang G.-C.; Ho C.-L.; Sequist L.V.; Dudek A.Z.; Shahidi M.; Cong X.J.; Lorence R.M.; Yang P.-C.; Miller V.A. |
| 臺大學術典藏 |
2022-06-10T06:11:13Z |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting
|
Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y. |
| 臺大學術典藏 |
2022-05-10T08:09:49Z |
Treatment outcomes of novel targeted agents in relapse/refractory chronic lymphocytic leukemia: A systematic review and network meta-analysis
|
Chen P.-H.; Ho C.-L.; Lin C.; Wu Y.-Y.; Huang T.-C.; YU-KANG TU; Lee C.-H. |
| 臺大學術典藏 |
2022-04-25T06:12:41Z |
Sesquiterpene Synthases of Zanthoxylum ailanthoides: Sources of Unique Aromas of a Folklore Plant in Taiwan
|
Chuang C.-W;Wen C.-H;Wu T.-J;Li C.-C;Chiang N.-T;Ma L.-T;Ho C.-L;Tung G.-S;Tien C.-C;Lee Y.-R;Chu F.-H.; Chuang C.-W; Wen C.-H; Wu T.-J; Li C.-C; Chiang N.-T; Ma L.-T; Ho C.-L; Tung G.-S; Tien C.-C; Lee Y.-R; Chu F.-H.; FANG-HUA CHU |
| 臺大學術典藏 |
2022-03-09T03:12:29Z |
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells
|
Li L.-H.; Wu P.; Lee J.-Y.; Li P.-R.; Hsieh W.-Y.; Ho C.-C.; Ho C.-L.; Chen W.-J.; Wang C.-C.; Yen M.-Y.; Yang S.-M.; HUEI-WEN CHEN |
| 國立成功大學 |
2022 |
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Na�ve Patients with�EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China
|
Tu, H.-Y.;Feng, J.;Shi, M.;Zhao, J.;Wang, Y.;Chang, J.;Wang, J.;Cheng, Y.;Zhu, J.;Tan, E.-H.;Li, K.;Zhang, Y.;Lee, V.;Yang, C.-T.;Su, W.-C.;Lam, D.C.-L.;Srinivasa, B.J.;Rajappa, S.;Ho, C.-L.;Lam, K.C.;Hu, Y.;Bondarde, S.A.;Liu, X.;Tian, Y.;Xue, Z.;Cseh, A.;Huang, D.C.-L.;Zhou, C.;Wu, Y.-L. |
| 國立成功大學 |
2022 |
Tip-Mediated Bandgap Tuning for Monolayer Transition Metal Dichalcogenides
|
Lin, M.-K.;Chen, G.-H.;Ho, C.-L.;Chueh, W.-C.;Hlevyack, J.A.;Kuo, C.-N.;Fu, T.-Y.;Lin, J.-J.;Lue, C.S.;Chang, W.-H.;Takagi, N.;Arafune, R.;Chiang, T.-C.;Lin, C.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:50Z |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting
|
Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y. |
| 臺大學術典藏 |
2021-01-12T12:49:02Z |
Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma
|
Ho C.-L.; Yeh S.-P.; Liu T.-C.; Wang P.-N.; Chang C.-S.; SHANG-YI HUANG; Kuo M.-C.; Lin H.-Y.; de Jong J.; Chen J.-Y.; Yang Y.-W. |
| 臺大學術典藏 |
2021-01-06T05:46:11Z |
Initial validation of a healthcare needs scale for young people with congenital heart disease
|
Chen C.-W.;Ho C.-L.;Su W.-J.;Jou-Kou Wang;Chung H.-T.;Lee P.-C.;Lu C.-W.;Hwang B.-T.; Chen C.-W.; Ho C.-L.; Su W.-J.; JOU-KOU WANG; Chung H.-T.; Lee P.-C.; Lu C.-W.; Hwang B.-T. |
| 國立成功大學 |
2021 |
High expression of kr�ppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, S.-L.;Shan, Y.-S.;Hsiao, C.-F.;Liu, T.-W.;Chen, J.-S.;Ho, C.-L.;Chou, W.-C.;Hsieh, R.-K.;Chen, L.-T.;Ch'ang, H.-J. |
| 國立成功大學 |
2021 |
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study
|
Harding, J.J.;Yang, T.-S.;Chen, Y.-Y.;Feng, Y.-H.;Yen, C.-J.;Ho, C.-L.;Huang, W.-T.;El, Dika I.;Akce, M.;Tan, B.;Cohen, S.A.;Meyer, T.;Sarker, D.;Lee, D.-W.;Ryoo, B.-Y.;Lim, H.Y.;Johnston, A.;Bomalaski, J.S.;O’Reilly, E.M.;Qin, S.;Abou-Alfa, G.K. |
| 臺大學術典藏 |
2020-12-09T09:01:01Z |
Initial validation of a healthcare needs scale for young people with congenital heart disease
|
Chen C.-W.;Ho C.-L.;Su W.-J.;Wang J.-K.;Chung H.-T.;Lee P.-C.;Chun-Wei Lu;Hwang B.-T.; Chen C.-W.; Ho C.-L.; Su W.-J.; Wang J.-K.; Chung H.-T.; Lee P.-C.; CHUN-WEI LU; Hwang B.-T. |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial
|
Yang J.C.H.; Shih J.-Y.; Su W.-C.; Hsia T.-C.; Tsai C.-M.; Ou S.H.I.; Yu C.-J.; Chang G.-C.; Ho C.-L.; Sequist L.V.; Dudek A.Z.; Shahidi M.; Cong X.J.; Lorence R.M.; PAN-CHYR YANG; Miller V.A. |
| 臺大學術典藏 |
2020-08-13T06:33:49Z |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial
|
Miller V.A.; Yang P.-C.; Lorence R.M.; Cong X.J.; Shahidi M.; Dudek A.Z.; Sequist L.V.; Yang J.C.H.; JIN-YUAN SHIH; Su W.-C.; Hsia T.-C.; Tsai C.-M.; Ou S.H.I.; Yu C.-J.; Chang G.-C.; Ho C.-L. |
| 臺大學術典藏 |
2020-08-13T06:33:42Z |
Epidermal growth factor receptor tyrosine Kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X/L861Q/S768I mutations
|
Chuang C.-Y.; Yu-Wung Yeh D.; Lin C.-B.; Hsiao S.-H.; Lin Y.-C.; Ho C.-L.; Hsia T.-C.; Wu M.-F.; Lai C.-L.; Lee K.-Y.; Wang C.-C.; Chiu C.-H.; Yang C.-T.; JIN-YUAN SHIH; Huang M.-S.; Su W.-C.; Lai R.-S.; Chang F.-K.; Tsai C.-M.; Perng R.-P.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-07-21T06:46:28Z |
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells
|
Li P.-R.; Hsieh W.-Y.; CHAO-CHI HO; Ho C.-L.; Chen W.-J.; Wang C.-C.; Yen M.-Y.; Yang S.-M.; Chen H.-W.; Lee J.-Y.; Wu P.; Li L.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:07Z |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial
|
Miller V.A.;Yang P.-C;Lorence R.M;Cong X.J;Shahidi M;Dudek A.Z;Sequist L.V;Ho C.-L;Chang G.-C;Yu C.-J;Ou S.H.I;Tsai C.-M;Hsia T.-C;Su W.-C;Shih J.-Y;Chih-Hsin Yang; CHIH-HSIN YANG; Shih J.-Y; Su W.-C; Hsia T.-C; Tsai C.-M; Ou S.H.I; Yu C.-J; Chang G.-C; Ho C.-L; Sequist L.V; Dudek A.Z; Shahidi M; Cong X.J; Lorence R.M; Yang P.-C; Miller V.A. |
| 臺大學術典藏 |
2020-05-26T09:26:49Z |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
|
Lux-Lung 5 Investigators;Serwatowski P;Kazarnowicz A;Jaskiewicz P;Palomino O.L.M;Pantigoso W.R;Barreda R.L.A;S?nchez J.F.S;Gans S;Herder G;Dingemans A.-M;Stigt J;Aerts J;Baca O.P;Luna G.A;Perez J.L.G;Delgado F.G;Cruciani G;Ceresoli G.L;Platania M;Milandri C;Gridelli C;Bearz A;Bidoli P;Migliorino M.R;Stemmer S;Gottfried M;Onn A;Nagarkar R.V;Dadhich H;Sharma L;Venkatesan S;Jain M;Prabhash K;Sarosi V;Strausz J;Tehenes S;Mark Z;Wiewrodt R;Dickgreber N;Huber R;Von Pawel J;Laack E;Keilholz U;Faehling M;Wehler T;Thomas M;Coudert B;Rotarski M;Gervais R;Fournel P;Bennouna J;Planchard D;Perol M;Sibilot D.M;Zalcman G;Chouaid C;Cadranel J;Alanko T;Riska H;Zadra C.A;Garicochea B;Zereu M;Lu S;Zhang Y;Huang J;Feng J;Qin S;Cheng Y;Liu X;Wu Y;Lin X;Thropay J;Meza L;Gurtler J;Summers Y;Upadhyay S;Brown E;Talbot T;Toy E;Spicer J;Popat S;Mitra S;Shah R;Polishchuk I;Bondarenko I;Ponomarova O;Popovych O;Vinnyk Y;Hsieh R.-K;Ho C.-L;Huang M.-S;Su W.-C;Tsao T.C.-Y;Chang G.-C;Tsai Y.-H;Chen Y.-M;Hsia T.-C;Yang C.-H;Kim Y.-C;Han J.-Y;Kim J.-H;Park K;Kim S.-W;Kim D.-W;Felip E;Cobo M;Lianes P;Campelo R.G;Camps C;Larriba J.L.G;Garrido P;Ragulin Y;Orlov S;Karaseva N;Lubennikov V;Jassem J;Szczesna A;Huang C;Wang J;Zhou C;Vercauter P;Delval L;Lambrechts M;Galdermans D;Carestia L;Bustin F;Humblet Y;Greil R;Mainwaring P;Crombie C;Underhill C;Parente P;Mclachlan S.-A;Richardet M;Blajman C;Zarba J.J;Recondo G;Martin C.M;Bagnes C;Planchard D;Chand V.K;Wang B;Zhou C;Wiewrodt R;Vinnyk Y;Strausz J;Lu S;Liu X;Kim D.-W;Grossi F;Feng J.-F;De Marinis F;Chouaid C;Chen Y.-M;Bennouna J;Kim J.-H;Park K;Chih-Hsin Yang;Schuler M; Zadra C.A; Riska H; Alanko T; Cadranel J; Chouaid C; Zalcman G; Sibilot D.M; Perol M; Planchard D; Bennouna J; Fournel P; Gervais R; Rotarski M; Coudert B; Thomas M; Wehler T; Faehling M; Keilholz U; Laack E; Von Pawel J; Huber R; Dickgreber N; Wiewrodt R; Mark Z; Tehenes S; Strausz J; Sarosi V; Prabhash K; Jain M; Venkatesan S; Sharma L; Dadhich H; Nagarkar R.V; Onn A; Gottfried M; Stemmer S; Migliorino M.R; Bidoli P; Bearz A; Gridelli C; Milandri C; Platania M; Ceresoli G.L; Cruciani G; Delgado F.G; Perez J.L.G; Luna G.A; Baca O.P; Aerts J; Stigt J; Dingemans A.-M; Herder G; Gans S; Sánchez J.F.S; Barreda R.L.A; Pantigoso W.R; Palomino O.L.M; Jaskiewicz P; Kazarnowicz A; Serwatowski P; Szczesna A; Jassem J; Lubennikov V; Karaseva N; Orlov S; Ragulin Y; Garrido P; Larriba J.L.G; Camps C; Campelo R.G; Lianes P; Cobo M; Felip E; Kim D.-W; Kim S.-W; Park K; Kim J.-H; Han J.-Y; Kim Y.-C; Yang C.-H; Hsia T.-C; Chen Y.-M; Tsai Y.-H; Chang G.-C; Tsao T.C.-Y; Su W.-C; Huang M.-S; Ho C.-L; Hsieh R.-K; Vinnyk Y; Popovych O; Ponomarova O; Bondarenko I; Polishchuk I; Shah R; Mitra S; Popat S; Spicer J; Toy E; Talbot T; Brown E; Upadhyay S; Summers Y; Gurtler J; Meza L; Thropay J; LUX-Lung 5 Investigators; Schuler M; CHIH-HSIN YANG; Park K; Kim J.-H; Bennouna J; Chen Y.-M; Chouaid C; De Marinis F; Feng J.-F; Grossi F; Kim D.-W; Liu X; Lu S; Strausz J; Vinnyk Y; Wiewrodt R; Zhou C; Wang B; Chand V.K; Planchard D; Bagnes C; Martin C.M; Recondo G; Zarba J.J; Blajman C; Richardet M; McLachlan S.-A; Parente P; Underhill C; Crombie C; Mainwaring P; Greil R; Humblet Y; Bustin F; Carestia L; Galdermans D; Lambrechts M; Delval L; Vercauter P; Zhou C; Wang J; Huang C; Lin X; Wu Y; Liu X; Cheng Y; Qin S; Feng J; Huang J; Zhang Y; Lu S; Zereu M; Garicochea B |
| 臺大學術典藏 |
2020-04-16T02:35:11Z |
Power analysis of bipartition and dual-encoding architecture for pipelined circuits
|
Ho, C.-L.; Lai, F.; FEI-PEI LAI; Naroska, E.; Ruan, S.-J. |
| 臺大學術典藏 |
2020-02-27T08:41:22Z |
Overexpression of neuronal intermediate filament protein α-internexin in PC12 cells
|
Chien C.-L.;Liu T.-C.;Ho C.-L.;Kuo-Shyan Lu; Chien C.-L.; Liu T.-C.; Ho C.-L.; KUO-SHYAN LU |
| 臺大學術典藏 |
2020-02-27T01:50:17Z |
Overexpression of neuronal intermediate filament protein α-internexin in PC12 cells
|
Lu K.-S.; Ho C.-L.; Liu T.-C.; CHUNG-LIANG CHIEN; Chung-Liang Chien;Liu T.-C.;Ho C.-L.;Lu K.-S. |
| 臺大學術典藏 |
2020-02-20T02:57:06Z |
Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: Identification of aurora kinase a as a poor risk marker
|
Yen C.-C.; Yeh C.-N.; Cheng C.-T.; Jung S.-M.; Huang S.-C.; Chang T.-W.; Jan Y.-Y.; Tzeng C.-H.; Chao T.-C.; Chen Y.-Y.; CHING-YAO YANG; Ho C.-L.; Fletcher J.A. |
